Sign in
Explore the registryTrack Mrna-1189's trials

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

MRNA-1189OngoingActive not recruitingPhase 1Open NCT05164094 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…